TTVR STRONG Under Coverage With Evidence Development (CED) Study

ConditionTricuspid Regurgitation

Trial statusRecruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

Age65+

SponsorEdwards Lifesciences

About this trial

This Coverage with Evidence Development (CED) study measures the long-term health outcomes of patients with severe, symptomatic Tricuspid Regurgitation who received a Transcatheter Tricuspid Valve Replacement procedure using the EVOQUE system.

Eligibility criteria

Qualifiers

None

Disqualifiers

None

Trial design

Treatments tested in this trial

EVOQUE

Treatment groups

2,044 Participants

are divided into 2 treatment groups

Sponsors and collaborators

Edwards Lifesciences

Lead sponsor

Source ClinicalTrials.gov